Abstract

Diet plays a crucial role in the development of colorectal cancer (CRC). Of particular importance, folate, present in foods and supplements, is a crucial modulator of CRC risk. The role of folate, and, specifically, the synthetic variant, folic acid, in the primary prevention of CRC has not been fully elucidated. Animal studies varied considerably in the timing, duration, and supplementation of folates, leading to equivocal results. Our work attempts to isolate these variables to ascertain the role of folic acid in CRC initiation, as we previously demonstrated that folate restriction conferred protection against CRC initiation in a β-pol haploinsufficient mouse model. Here we demonstrated that prior adaptation to folate restriction altered the response to carcinogen exposure in wild-type C57BL/6 mice. Mice adapted to folate restriction for 8 weeks were protected from CRC initiation compared to mice placed on folate restriction for 1 week, irrespective of antibiotic supplementation. Through analyses of mTOR signaling, DNA methyltransferase, and DNA repair, we have identified factors that may play a critical role in the differential responses to folate restriction. Furthermore, the timing and duration of folate restriction altered these pathways differently in the absence of carcinogenic insult. These results represent novel findings, as we were able to show that, in the same model and under controlled conditions, folate restriction produced contrasting results depending on the timing and duration of the intervention.

Highlights

  • Colorectal cancer (CRC) is the second most common reported cancer in western societies

  • Our analysis revealed an upward trend in the NAD+/NADH ratio between the folate restriction (FR) DMH and folate adequate groups (FA) DMH groups; SIRT1 expression was significantly increased in both folate-restricted diet for one week (FA/FR) DMH and FR DMH compared to FA DMH

  • Our study reveals that the adaptation to folate restriction occurs prior to DMH initiation during the preceding 7 weeks of folate restriction imposed on FR mice, compared to 1 week in FA/FR mice

Read more

Summary

Introduction

Colorectal cancer (CRC) is the second most common reported cancer in western societies. Over the past 2 decades, there have been a multitude of reports by independent groups that challenged our understanding of the role of dietary folate in cancer initiation and progression. These reports have been thoroughly reviewed elsewhere [2,3,4,5,6,7,8,9]. An overview of rodent studies examining the impact of folic acid on CRC revealed that the interventions differed in the use of animal models, diets, folic acid supplementation, antibiotic use, and the type of caging [12,13,14,19,20,21,22,23,24,25]. A comparative analysis of the experimental design and endpoints of these studies is reviewed elsewhere [26]

Methods
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call